Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate

Journal of Clinical Investigation

Volumn 97, Issue 10, 1996, Pages 2233-2241

  Grass, David S ^a   Felkner, Roland H ^a   Chiang, Ming Yi ^b   Wallace, Racheal E ^a   Nevalainen, Timo J ^c   Bennett, C Frank ^b   Swanson, Mark E ^a  

^a Chrysalis DNX Transgenic Sciences   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

epidermal hyperplasia; group II PLA2; hyperkeratosis; inflammation; transgenic mice

Indexed keywords

DNA; PHOSPHOLIPASE A2; RNA;

ADNEXA DISEASE; ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS HYPERPLASIA; FEMALE; GENE EXPRESSION; HISTOLOGY; HYPERKERATOSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0029882783     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118664     Document Type: Article

References (68)

1. Van Deenen, L.L.M., and G.H. de Haas. 1963. The substrate specificity of phospholipase A. Biochim. Biophys. Acta. 70:538-553.
2. Van Den Bosch, H., and L.L.M. Van Deenen. 1965. Chemical structure and biochemical significance of lysolecithins from rat liver. Biochim. Biophys. Acta. 106:326-337.
3. Van den Bosch, H. 1980. Intracellular Phospholipases A. Biochim. Biophys. Acta. 604:191-246.
4. Waite, M. 1987. The Phospholipases. Plenum Publishing Corp., New York. 332 pp.
5. Dennis, E.A., S.G. Rhee, M.M. Billah, and Y.A. Hannun. 1991. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5:2068-2077.
6. 2: protection from peroxidation damage. Trends Biochem. Sci. 12:31-34.
7. 2 in inflammatory diseases. Clin. Chem. 39:2453-2459.
8. 2 in the pathobiology of disease. Lab. Invest. 55:391-404.
9. Dennis, E.A. 1987. Regulation of eicosanoid production: role of phospholipase and inhibitors. Biotechnology. 5:1294.
10. 2 in inflammed sites. Dermatologica. 179:72-76.
11. Vane, J.R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for asprin-like drugs. Nature New Biol. 231:232-235.
12. Smith, J.B. and A.L. Willis. 1971. Aspirin selectively inhibits prostaglandin production in human platelets. Nat. New Biol. 231:235-237.
13. Samuelson, B., S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science (Wash. DC). 237:1171-1175.
14. Lam, B.K., and K.F. Austen. 1992. Leukotrienes: biosynthesis, release, and actions. In Inflammation: Basic Principles and Clinical Correlates, second edition. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, Ltd., New York. 139-147.
15. 2: a mediator between proximal and distal effectors of inflammation. Immunol. Today. 12:143-146.
16. 2-α from the venom of crotalus adamanteus. J.Biol. Chem. 252:4913-4921.
17. Davidson, F.F., and E.A. Dennis. 1990. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J. Mol. Evol. 31:228-238.
18. 2. J. Biol. Chem. 269:2365-2368.
19. 2s; comparison of arachidonyl-selective and -nonselective enzymes. FASEB J. 342:339-348.
20. 2. J. Biol. Chem. 269:13057-13060.
21. 2 and lysophoshpatidylserine-specific lysophospholipase from rat platelets. J. Biochem. (Tokyo). 101:53-61.
22. 2 and its characteristics. J. Biochem. (Toyko). 105:520-525.
23. 2. J. Biol. Chem. 264:5768-5775.
24. 2 purified from an inflammatory exudate. Biochemistry. 25:8381-8385.
25. 2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett. 273:23-26.
26. 2 from rat spleen. J. Biol. Chem. 263:5732-5738.
27. 2. J. Biol. Chem. 264:10008-10014.
28. 2 (type II) in human placenta and its involvement in normal parturition at term. Prostaglandins Leukot. Essent. Fatty Acids. 51:19-26.
29. 2 in cartilage. J. Rheumatol. 20:325-330.
30. 2 in human seminal plasma. Andrologia. 25:355-358.
31. 2 by lacrimal gland. Invest. Opthalmal. Vis. Sci. 32:417-421.
32. 2: purification and some molecular characteristics. Biochemistry. 21:6883-6889.
33. 2 in the human gastrointestinal tract. Lab. Invest. 72: 201-208.
34. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1043-1051.
35. 2 in cultured mast cells. J. Biochem. 111:175-181.
36. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. USA. 87:7708-7712.
37. 2 in human acute pancreatis. Scand. J. Gastroenterol. 15: 633-636.
38. 2 from human synovial fluid in rheumatoid arthritis. J. Biochem.(Toyko). 105: 395-399.
39. 2 in rheumatoid synovial fluid. Life Sci. 36:579-587.
40. 2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335-5338.
41. 2 levels with circulatory collapse. Crit. Care Med. 16:1-7.
42. 2 levels: correlation with hemodynamic and pulmonary changes in gram-negative septic shock. J. Lab. Clin. Med. 104:873-881.
43. 2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema. Br. J. Dermatol. 112:135-147.
44. 2 activity is raised in the uninvolved skin of psoriasis. Br. J. Dermatol. 108:103-105.
45. 2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion. 52:232-236.
46. 2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation. 15:355-367.
47. 2 induces an inflammatory response in rabbit joints. J. Immunol. 146:3904-3910.
48. 2. Am. J. Pathol. 134:807-811.
49. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. 497 pp.
50. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-cloroform extraction. Anal. Biochem. 162:156-159.
51. 2 by "lipocortins" and calpactins. J. Biol. Chem. 262: 1698-1705.
52. Hsu, S.M., L. Raine, and H. Fanger. 1981. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580.
53. Rosenberg, A.S. 1991. Skin allograft rejection. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. Green Publishing Associates and Wiley-Interscience, New York.
54. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266:2647-2651.
55. Grayson, D.R., R.H. Costa, and J.E. Darnell. 1989. Regulation of hepatocyte-specific gene expression. Ann. NY Acad. Sci. USA. 557:243-255.
56. 2 gene. Biochemistry. 33:7134-7145.
57. Min-induced intestinal neoplasia. Cell. 81:957-966.
58. 2 gene in inbred mouse strains. J. Biol. Chem. 270:22378-22385.
59. 2 in rabbits. J. Invest. Dermatol. 86:380-383.
60. Barrandon, Y., and H. Green. 1987. Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell. 50:1131-1137.
61. Vassar, R., and E. Fuchs. 1991. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes & Dev. 5:714-727.
62. Margolis, B.L., J.V. Bonventre, S.G. Kremer, J.E. Kudlow, and K.L. Skorecki. 1988. Epidermal growth factor is synergistic with phorbol esters and vasopressin in stimulating arachidonate release and prostaglandin production in renal glomerular cells. Biochem. J. 249:587-592.
63. Sibilia, M., and E.F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science (Wash. DC). 269:234-237.
64. Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D.Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, J.A. Barnard, S.H. Yuspa, R.J. Coffee, and T. Magnuson. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (Wash. DC). 269:230-234.
65. 2 in vasopressin-treated rat glomerular mesangial cells. Biochem. J. 256:469-474.
66. 2. J. Biol. Chem. 269:1575-1578.
67. 2 in Swiss 3T3 cells via specific binding site. J. Biol. Chem. 266:19139-19141.
68. Bouclier, M., B. Luginbuhl, F. Delamadeleine, P. Rossio, and C. Hensby. 1989. Repeated application of arachidonic acid to the ear of mice: a model of chronic skin inflammation? Agents and Actions. 26:227-228.